UCB:EBR
UCB SA
€204,60
arrow_downward
-0,68%(-1,40) 1D
16 Okt., 17:37:21 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCB...
Open
€204,50
High
€205,10
Low
€201,30
Mkt. cap
38,32Â mjd
Avg. vol.
248,57Â k
Volume
324,45Â k
Dividend
0,50%
Quarterly dividend
€0,25
Ex-dividend date
04 Mei 2026
P/E ratio
18,09
52-wk high
€289,50
52-wk low
€197,45
EPS
€11,31
Shares outstanding
194,51Â m
No. of employees
9Â k
Open
€204,50
High
€205,10
Low
€201,30
Mkt. cap
38,32Â mjd
Avg. vol.
248,57Â k
Volume
324,45Â k
Dividend
0,50%
Quarterly dividend
€0,25
Ex-dividend date
04 Mei 2026
P/E ratio
18,09
52-wk high
€289,50
52-wk low
€197,45
EPS
€11,31
Shares outstanding
194,51Â m
No. of employees
9Â k
News stories
From web sources and news partners
ad-hoc-news.de
·
12 uur gelede
Deutsche Bank keeps EUR 295.00 target for UCB stock
ad-hoc-news.de
·
17 uur gelede
UCB revises Bimzelx potential above EUR 7 billion: UCB stock sits 30.28 percent below its high
ad-hoc-news.de
·
20 uur gelede
UCB stock pre-market at EUR 206.55 on October 16, 2026
ad-hoc-news.de
·
1 dag gelede
UCB dedicates Georgia campus as UCB stock sits 29.15 percent below its high
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9Â k
Founded18 Jan. 1928
Headquarters-
SectorPharmaceutical industry
Websiteucb.com